header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

Intra-Operative Cell Salvage in Primary Hip Arthroplasty

International Society for Technology in Arthroplasty (ISTA)



Abstract

Introduction:

Intraoperative cell salvage involves the collection of blood directly from the operative field. The purpose of this study was to determine if its use reduces the need for postoperative allogenic blood transfusion, assess any adverse events and its effect on duration of postoperative stay in primary hip arthroplasty.

Patients and Methods:

We prospectively examined the effect of intraoperative cell salvage on the need for postoperative allogenic blood transfusion. Between February 2009 and August 2010, a total of 77 patients who underwent primary total hip arthroplasty were included in the study, under the care of the senior author (KB). All patients had a diagnosis of osteoarthritis.

Intraoperative cell salvage was used in 38 patients and not used in 39 patients. We prospectively collected data on patient demographics, ASA grade, preoperative and postoperative haematological features, number of units of packed red cells transfused and the volume of intraoperative reinfused cell salvaged blood. Total inpatient stay and any postoperative adverse events were recorded.

Results:

  • No patients in the cell salvage group required postoperative allogenic blood transfusion compared to three patients (7.7%) in the conventional group.

  • Postoperative decrease in haemoglobin was less in the cell salvage group (2.57 vs. 3.3 g/dL).

  • The mean length of postoperative inpatient stay was shorter in the cell salvage group (5.1 vs. 6.41 days).

  • Three patients in the cell salvage group had adverse events (1 UTI, 1 hyponatraemia, 1 colonic pseudo-obstruction).

  • Three patients in the conventional group experienced adverse events (2 superficial wound infections, 1 DVT).

  • An average of 361 mls of cell salvaged blood was reinfused (110–900 mls).

Conclusions:

We have found that the use of intraoperative cell salvage in patients undergoing primary total hip arthroplasty reduces the need for post operative allogenic blood transfusion with no increase in adverse events when compared to conventional measures of blood preserving techniques.


*Email: